CASSS has started a new discussion group in the Netherlands. The Netherlands Area Biotech (NLab) Discussion Group is the first CASSS discussion group located outside the U.S. It is intended to enable the local area community of industry, academic and regulatory professionals to meet and share ideas and experiences, thereby working together to resolve scientific challenges in the field of biopharmaceutical development and regulation.

The NLab discussion group goals include:

Share learning across industry, academia and health authorities in Europe in general, and in the Netherlands in particular

Generate new scientific and technical insights and solutions for developing biopharmaceutical products in the future

Contribute to the expansion of CASSS’s mission, vision, influence, and community in Europe

Who Should Attend

Anyone from industry, academia or regulatory affiliated with biotechnology or interested in learning more about the scientific and technological applications to and regulatory trends in biotechnology.

When and Where

Meetings will be held quarterly from 17:00 to 20:00 unless otherwise noted. They will be organized at various locations throughout the Netherlands. The first meeting was held Wednesday, 12 April 2017, in Leiden.

Submit an Abstract

The Program Committee is accepting abstracts for oral presentations on an ongoing basis. To submit an abstract, click here. Please email Amy Cano at acano@casss.org if you have any further questions.

Additional Links

Our site uses cookies to improve your experience. You can find out more about our use of cookies
in our "standard cookie policy", including
instructions on how to reject and delete cookies if you wish to do so. By continuing to browse this site you agree
to us using cookies as described in our "standard cookie policy".

Our site uses cookies to improve your experience. You can find out more about our use of cookies
in our "standard cookie policy", including
instructions on how to reject and delete cookies if you wish to do so. By continuing to browse this site you agree
to us using cookies as described in our "standard cookie policy".